United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 373,600 | 362,600 | 381,400 | 412,700 | 444,500 |
| Cost of Goods | 26,700 | 29,100 | 31,900 | 51,900 | 61,700 |
| Gross Profit | 346,900 | 333,500 | 349,500 | 360,800 | 382,800 |
| Operating Expenses | 126,200 | 989,500 | 218,900 | 212,100 | 166,100 |
| Operating Income | 221,400 | -655,900 | 131,500 | 149,600 | 217,400 |
| Interest Expense | 12,200 | 10,300 | 4,300 | 4,100 | 2,900 |
| Other Income | 41,200 | 15,600 | -35,300 | -5,400 | 3,400 |
| Pre-tax Income | 250,400 | -650,600 | 91,900 | 140,100 | 217,900 |
| Income Tax | 45,300 | -156,000 | 26,600 | 33,600 | 45,000 |
| Net Income Continuous | 205,100 | -494,600 | 65,300 | 106,500 | 172,900 |
| Net Income | $205,100 | $-494,600 | $65,300 | $106,500 | $172,900 |
| EPS Basic Total Ops | 4.68 | -11.32 | 1.44 | 2.44 | 4.01 |
| EPS Basic Continuous Ops | 4.68 | -11.32 | 1.44 | 2.44 | 4.01 |
| EPS Diluted Total Ops | 4.66 | -11.32 | 1.42 | 2.42 | 3.98 |
| EPS Diluted Continuous Ops | 4.66 | -11.32 | 1.42 | 2.42 | 3.98 |
| EBITDA(a) | $231,800 | $-645,600 | $142,000 | $159,000 | $225,500 |